| 25 May 2026 |
Arimidex (Anastrozole) |
8.8 |
25mg |
30.9mg |
+23.5% |
95.11% |
Lab B |
| 25 May 2026 |
Masteron P (Drostanolone P) |
5.7 |
300mg/ml |
312.1mg/ml |
+4.0% |
96.78% |
Lab G |
| 24 May 2026 |
NAD+ 100mg + Mots-C 10mg + 5-Amino 1MQ 10mg Blend |
9.6 |
2mg |
1.8mg |
-11.6% |
99.93% |
Lab G |
| 24 May 2026 |
IGF-1 LR3 |
9.9 |
10mg |
9.3mg |
-6.8% |
97.15% |
Lab E |
| 24 May 2026 |
Hyaluronic acid |
8.0 |
50mg |
58.9mg |
+17.8% |
98.81% |
Lab E |
| 24 May 2026 |
MT-1 |
6.8 |
30mg |
35.9mg |
+19.6% |
98.60% |
Lab F |
| 24 May 2026 |
Trenbolone Acetate |
7.9 |
250mg/ml |
286.1mg/ml |
+14.4% |
95.25% |
Lab G |
| 24 May 2026 |
17a-Methyl-1-Testosterone |
4.6 |
25mg |
25.2mg |
+0.7% |
96.09% |
Lab E |
| 24 May 2026 |
5-amino-1MQ |
4.0 |
2mg |
2.5mg |
+24.6% |
98.38% |
Lab F |
| 24 May 2026 |
L-Carnitine 500mg |
9.1 |
300mg/ml |
370.6mg/ml |
+23.5% |
96.32% |
Lab F |
| 24 May 2026 |
Sleep Blend (GABA 100mg+Histidine 100mg+L-Theanine 50mg+Taurine 100mg+Melatonin 2mg) |
8.0 |
250mg/ml |
237.9mg/ml |
-4.8% |
98.10% |
Lab A |
| 24 May 2026 |
GLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg |
6.4 |
20mg |
23.0mg |
+14.8% |
96.28% |
Lab A |
| 24 May 2026 |
HGH 191AA (Somatropin) |
4.2 |
50mg |
55.2mg |
+10.4% |
97.81% |
Lab C |
| 24 May 2026 |
NAD+ |
5.8 |
15mg |
15.2mg |
+1.0% |
95.91% |
Lab A |
| 24 May 2026 |
Selank |
5.6 |
15mg |
17.7mg |
+18.1% |
96.96% |
Lab E |
| 23 May 2026 |
Tirzepatide |
8.3 |
30mg |
29.9mg |
-0.3% |
99.17% |
Lab E |
| 23 May 2026 |
BMK glycidic acid (P-2-P methyl glycidic acid / sodium salt) CAS 5449-12-7 |
4.0 |
100g |
116.6g |
+16.6% |
99.21% |
Lab F |
| 23 May 2026 |
T3 (Liothyronine) |
8.4 |
10mg |
11.8mg |
+17.7% |
98.77% |
Lab F |
| 23 May 2026 |
Thymalin |
4.2 |
50mg |
43.9mg |
-12.1% |
95.94% |
Lab F |
| 23 May 2026 |
Clenbuterol |
6.6 |
10mg |
11.0mg |
+9.6% |
97.52% |
Lab B |
| 21 May 2026 |
Retatrutide |
8.8 |
10mg |
9.12mg |
-8.8% |
99.90% |
Lab E |
| 21 May 2026 |
Cardiogen |
4.0 |
2mg |
2.2mg |
+9.8% |
99.65% |
Lab D |
| 19 May 2026 |
Flibanserin |
6.9 |
50mg |
44.1mg |
-11.9% |
95.66% |
Lab E |
| 29 Jan 2026 |
Retatrutide |
8.0 |
10mg |
10.7mg |
+7.0% |
99.33% |
Lab E |
| 29 Jan 2026 |
Retatrutide |
7.0 |
20mg |
20.5mg |
+2.5% |
97.50% |
Lab E |
| 29 Jan 2026 |
GHRP-2 Acetate |
5.3 |
10mg |
10.2mg |
+2.2% |
95.21% |
Lab C |
| 26 Jan 2026 |
DSIP |
5.1 |
10mg |
9.0mg |
-9.6% |
97.88% |
Lab F |
| 9 Jan 2026 |
Chonluten |
7.7 |
50mg |
61.6mg |
+23.2% |
99.11% |
Lab D |
| 9 Jan 2026 |
PEG MGF |
6.1 |
2mg |
2.0mg |
-0.6% |
95.85% |
Lab E |
| 12 Dec 2025 |
Alprostadil |
5.7 |
15mg |
13.6mg |
-9.0% |
98.76% |
Lab F |
| 12 Dec 2025 |
Livagen |
5.8 |
5mg |
6.1mg |
+21.8% |
95.48% |
Lab D |
| 12 Dec 2025 |
RIPEX 225 (TRA/Mast P/Test P) |
4.0 |
250mg/ml |
253.6mg/ml |
+1.4% |
96.63% |
Lab E |
| 12 Dec 2025 |
Vitamin B12 1mg/ml |
8.2 |
100mg/ml |
107.5mg/ml |
+7.5% |
96.29% |
Lab E |
| 25 Nov 2025 |
Tirzepatide |
6.7 |
10mg |
9.31mg |
-6.9% |
99.64% |
Lab E |
| 23 Nov 2025 |
Super Shred |
4.1 |
250mg/ml |
243.6mg/ml |
-2.6% |
99.66% |
Lab A |
| 23 Nov 2025 |
Test Suspension |
4.3 |
300mg/ml |
292.2mg/ml |
-2.6% |
99.23% |
Lab A |
| 17 Nov 2025 |
Retatrutide |
8.6 |
5mg |
4.75mg |
-5.0% |
99.30% |
Lab E |
| 17 Nov 2025 |
AHK-CU |
5.3 |
20mg |
17.2mg |
-14.0% |
99.83% |
Lab G |
| 14 Nov 2025 |
Cerebrolysin |
6.6 |
30mg |
25.8mg |
-13.9% |
96.46% |
Lab B |
| 5 Nov 2025 |
ACE-031 |
4.5 |
20mg |
24.1mg |
+20.4% |
98.40% |
Lab F |
| 5 Nov 2025 |
PE 22-28 |
4.9 |
30mg |
33.7mg |
+12.3% |
95.46% |
Lab A |
| 4 Nov 2025 |
1-Boc-4-(4-fluorophenylamino)piperidine CAS 288573-56-8 |
7.7 |
500g |
504.4g |
+0.9% |
99.62% |
Lab D |
| 4 Nov 2025 |
Retatrutide 5mg + Cagrilintide 5mg Blend |
5.2 |
2mg |
2.4mg |
+20.1% |
95.70% |
Lab C |
| 4 Nov 2025 |
Trestolone Enanthate Raw |
4.0 |
10g |
11.1g |
+10.9% |
99.64% |
Lab G |
| 13 Oct 2025 |
Retatrutide |
7.3 |
10mg |
11mg |
+10.0% |
99.40% |
Lab G |
| 9 Oct 2025 |
Testosterone Decanoate Raw |
4.0 |
10g |
9.8g |
-1.6% |
98.27% |
Lab A |